Skip to main content
Clinical Trials/NCT01402258
NCT01402258
Completed
Not Applicable

Tailored Internet-administrated Treatment of Anxiety Symptoms for Young Adults

Linkoeping University1 site in 1 country15 target enrollmentApril 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety Disorders
Sponsor
Linkoeping University
Enrollment
15
Locations
1
Primary Endpoint
Beck Anxiety Inventory (BAI)- Change from baseline
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to determine whether tailored internet-administrated CBT is a feasible approach in the treatment of anxiety symptoms and comorbid anxiety and depressive symptoms in a clinical setting.

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
June 2015
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Linkoeping University
Responsible Party
Principal Investigator
Principal Investigator

Gerhard Andersson

Professor

Linkoeping University

Eligibility Criteria

Inclusion Criteria

  • Be between the ages of 16-25 years old
  • Have anxiety symptoms and/or anxiety syndrome

Exclusion Criteria

  • Suicide prone
  • Alcohol addiction
  • Ongoing psychological treatment

Outcomes

Primary Outcomes

Beck Anxiety Inventory (BAI)- Change from baseline

Time Frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment

Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.

Secondary Outcomes

  • Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)- Change from baseline(Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment)
  • Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)- Change from baseline(Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment)
  • Quality of Life Inventory (QOLI)- Change from baseline(Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment)

Study Sites (1)

Loading locations...

Similar Trials